Jung R, Krüger W, Hosch S, Holweg M, Kröger N, Gutensohn K, Wagener C, Neumaier M, Zander A R
Department of Clinical Chemistry, University Hospital Eppendorf, Hamburg, Germany.
Br J Cancer. 1998 Nov;78(9):1194-8. doi: 10.1038/bjc.1998.653.
Several reverse transcriptase polymerase chain reaction (RT-PCR) assays have been described for the detection of circulating tumour cells in blood and bone marrow. Target mRNA sequences for this purpose are the cytokeratins (CK) 19 and 20, the carcinoembryonic antigen (CEA), and the prostate-specific antigen messages. In this study, we investigated biological factors influencing the specificity of the CK19 and CEA RT-PCR assays. Bone marrow, granulocyte colony-stimulating factor (G-CSF)-mobilized blood stem cells and peripheral blood samples obtained from healthy volunteers (n = 15; CEA n = 7), from patients with epithelial (n = 29) and haematological (n = 23) cancer and from patients with chronic inflammatory diseases (n = 16) were examined. Neither CEA nor cytokeratin 19 messages could be amplified from bone marrow samples from healthy subjects and from patients with haematological malignancies. In contrast, specimens from patients with inflammatory diseases scored positive up to 60%. To investigate the influence of inflammation on target mRNA expression, haemopoietic cells were cultured with and without cytokine stimulation in vitro. CK19 messages could be easily detected in cultured marrow cells without further stimulation, CEA messages only after gamma-interferon (gamma-INF) stimulation. In contrast, G-CSF-mobilized peripheral blood stem cells were positive for CK19 messages only after stem cell factor (SCF) or interleukin stimulation. We conclude that transcription of so-called tissue-specific genes is inductible in haemopoietic tissues under certain conditions. These factors have to be considered in future applications of RT-PCR for the detection of minimal residual disease.
已有多种逆转录酶聚合酶链反应(RT-PCR)检测方法用于检测血液和骨髓中的循环肿瘤细胞。用于此目的的靶mRNA序列包括细胞角蛋白(CK)19和20、癌胚抗原(CEA)以及前列腺特异性抗原信息。在本研究中,我们调查了影响CK19和CEA RT-PCR检测特异性的生物学因素。检测了从健康志愿者(n = 15;CEA检测n = 7)、上皮癌患者(n = 29)、血液系统癌症患者(n = 23)以及慢性炎症疾病患者(n = 16)获取的骨髓、粒细胞集落刺激因子(G-CSF)动员的血液干细胞和外周血样本。健康受试者和血液系统恶性肿瘤患者的骨髓样本中均未扩增出CEA和细胞角蛋白19信息。相比之下,炎症疾病患者的样本阳性率高达60%。为了研究炎症对靶mRNA表达的影响,在体外对造血细胞进行了有无细胞因子刺激的培养。未经进一步刺激的培养骨髓细胞中可轻易检测到CK19信息,仅在γ干扰素(γ-INF)刺激后可检测到CEA信息。相比之下,G-CSF动员的外周血干细胞仅在干细胞因子(SCF)或白细胞介素刺激后CK19信息呈阳性。我们得出结论,在某些条件下,造血组织中所谓的组织特异性基因的转录是可诱导的。在未来应用RT-PCR检测微小残留病时必须考虑这些因素。